Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lorenzo GD et al. – In past years, there have been considerable advances in the understanding of renal cell carcinoma (RCC) biology. These advances have been translated into the development of several drugs with improved efficacy. Uro–oncologists today have a plethora of treatment options for metastatic RCC patients. Our knowledge will continue to evolve as new data become available, and we hope that knowledge translates to increased efficacy for patients.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address